VIVO  valuation analysis

Basics
Name: Meridian Bioscience, Inc
Description: Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 07, 2021
Market cap: $759.56M (1315th)
Sales(TTM): $327.13M (1291st)
Earnings(TTM): $87.08M (877th)

Value
FFER: 0.53*
Actual price: $17.53
* Earnings were reported Aug 06, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Meridian Bioscience, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Meridian Bioscience, Inc
"Diagnostics & Research" industry
Book / MarketCap
Meridian Bioscience, Inc
"Diagnostics & Research" industry
Equity / Assets
Meridian Bioscience, Inc
"Diagnostics & Research" industry